SNCA, PARK2 and LRRK-2 mutations in Polish patients with sporadic Parkinson’s disease
Anna Półrolniczak(Poznan University of Medical Sciences), Wojciech Kozubski(Poznan University of Medical Sciences), Michał K. Owecki(Poznan University of Medical Sciences), Paweł P. Jagodzińśki(Poznan University of Medical Sciences), Błażej Rubiś(Poznan University of Medical Sciences), Agata Różycka(Poznan University of Medical Sciences), Jolanta Florczak(Poznan University of Medical Sciences), Jolanta Dorszewska(Poznan University of Medical Sciences)
Acta Neurobiologiae Experimentalis
January 1, 2011
Cited by 0
Related Papers
Advances in the Potential Biomarkers of Epilepsy
|Frontiers in Neurology|2019|145
Vitamin C as a Modulator of the Response to Cancer Therapy
|Molecules|2019|104
Telomerase and drug resistance in cancer
|Cellular and Molecular Life Sciences|2017|102
The non-canonical functions of telomerase: to turn off or not to turn off
|Molecular Biology Reports|2018|61
Opioid Receptors in Psoriatic Skin: Relationship with Itch
|Acta Dermato Venereologica|2016|42